Fund shareholders of ACURX PHARMACEUTICALS INC
ISIN US00510M2035 · United States · LEI 5493006KI0IEUHE1UK56
- Fund shareholders
- 5
- Of which ETFs
- 0 5 other funds
- Value held
- 136K $
- Share of capital
- 0.8 % of 5.3M shares on Aug 13, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 31,099 | 115.4K $ | 0.00 % | 0.59 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 11,494 | 17.4K $ | 0.22 % | as of Feb 28, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 1,001 | 1.5K $ | 0.02 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 993 | 1.5K $ | 0.02 % | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 146 | 220.5 $ | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 5 | 0 | 44,733 | +220.3 % |
| 2026Q1 | 5 | -1 | 13,968 | -8.6 % |
| 2025Q4 | 6 | 15,275 |
Institutional managers
20 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| JANE STREET GROUP, LLC | 54,642 | 202.7K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 24,819 | 92.1K $ | as of Mar 31, 2026 |
| Cambridge Investment Research Advisors, Inc. | 20,000 | 74 $ | as of Mar 31, 2026 |
| Prospect Financial Services LLC | 13,785 | 51.1K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 6,500 | 24.1K $ | as of Mar 31, 2026 |
| UBS Group AG | 6,312 | 23.4K $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 2,300 | 8.5K $ | as of Mar 31, 2026 |
| Westside Investment Management, Inc. | 1,650 | 6.1K $ | as of Mar 31, 2026 |
| NBC SECURITIES, INC. | 1,500 | 5.6K $ | as of Mar 31, 2026 |
| Western Wealth Management, LLC | 1,325 | 4.9K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,031 | 3.8K $ | as of Mar 31, 2026 |
| MCGUIRE CAPITAL ADVISORS INC | 1,000 | 3.7K $ | as of Mar 31, 2026 |
| BARCLAYS PLC | 380 | 1.4K $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 245 | 909 $ | as of Mar 31, 2026 |
| Cornerstone Planning Group LLC | 167 | 334 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 100 | 371 $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 60 | 223 $ | as of Mar 31, 2026 |
| Advisory Services Network, LLC | 59 | 219 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 6 | 22 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1 | 4 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of ACURX PHARMACEUTICALS INC". https://titelia.com/en/stocks/acurx-pharmaceuticals-inc-US00510M2035